214 related articles for article (PubMed ID: 15506424)
21. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway.
Grosser N; Schröder H
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1345-51. PubMed ID: 12829521
[TBL] [Abstract][Full Text] [Related]
22. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
Bellingham M; Evans TJ
Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
[TBL] [Abstract][Full Text] [Related]
23. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum.
Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V
J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension.
Schulz E; Jansen T; Wenzel P; Daiber A; Münzel T
Antioxid Redox Signal; 2008 Jun; 10(6):1115-26. PubMed ID: 18321209
[TBL] [Abstract][Full Text] [Related]
25. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
[TBL] [Abstract][Full Text] [Related]
26. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
[TBL] [Abstract][Full Text] [Related]
27. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.
Bai Y; Ye S; Mortazavi R; Campese V; Vaziri ND
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F974-80. PubMed ID: 17122386
[TBL] [Abstract][Full Text] [Related]
28. Handbook of Experimental Pharmacology 191. cGMP: generators, effectors and therapeutic implications. Preface.
Schmidt HH; Hofmann F; Stasch JP
Handb Exp Pharmacol; 2009; (191):v-vi. PubMed ID: 19192509
[No Abstract] [Full Text] [Related]
29. There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling.
Nedvetsky PI; Sessa WC; Schmidt HH
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16510-2. PubMed ID: 12486234
[No Abstract] [Full Text] [Related]
30. Nitric oxide and carbon monoxide synthesizing enzymes and soluble guanylyl cyclase within neurons of adult human cardiac ganglia.
Singh S; Gray T; Wurster RD
Auton Neurosci; 2009 Jan; 145(1-2):93-8. PubMed ID: 19106038
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
32. Regulation of nitric oxide-sensitive guanylyl cyclase.
Friebe A; Koesling D
Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
[TBL] [Abstract][Full Text] [Related]
33. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis.
Van Crombruggen K; Van Nassauw L; Demetter P; Cuvelier C; Timmermans JP; Lefebvre RA
Eur J Pharmacol; 2008 Jan; 579(1-3):337-49. PubMed ID: 18022154
[TBL] [Abstract][Full Text] [Related]
34. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
Reyna-Neyra A; Sarkar G; Etgen AM
J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands.
Palacios M; Knowles RG; Palmer RM; Moncada S
Biochem Biophys Res Commun; 1989 Dec; 165(2):802-9. PubMed ID: 2480784
[TBL] [Abstract][Full Text] [Related]
36. NO or H(2)O(2) for endothelium-dependent vasorelaxation: Tetrahydrobiopterin makes the difference.
van Hinsbergh VW
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):719-21. PubMed ID: 11348862
[No Abstract] [Full Text] [Related]
37. Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxide.
Jarry A; Renaudin K; Denis MG; Robard M; Buffin-Meyer B; Karam G; Buzelin F; Paris H; Laboisse CL; Vallette G
Kidney Int; 2003 Jul; 64(1):170-80. PubMed ID: 12787407
[TBL] [Abstract][Full Text] [Related]
38. Vascular nitric oxide: Beyond eNOS.
Zhao Y; Vanhoutte PM; Leung SW
J Pharmacol Sci; 2015 Oct; 129(2):83-94. PubMed ID: 26499181
[TBL] [Abstract][Full Text] [Related]
39. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study.
Marcoli M; Maura G; Cervetto C; Giacomini C; Oliveri D; Candiani S; Pestarino M
Neurochem Int; 2006 Dec; 49(7):683-90. PubMed ID: 16904241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
